Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00363272
First received: August 10, 2006
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)